SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical launches special initiative ‘Sunkalp’ for welfare of doctors

01 Jul 2021 Evaluate

Sun Pharmaceutical Industries and includes its subsidiaries and/or associate companies) have launched special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. Doctors have been working relentlessly through the pandemic putting their lives at risk to safeguard society. To recognise and care for their health & well-being, on the occasion of National Doctors' Day, Sun Pharma launches multifaceted initiatives under Sunkalp.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1668.00 -7.20 (-0.43%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×